These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10311722)

  • 1. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
    Khanderia U
    Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-benefit analysis of an aminoglycoside monitoring service.
    Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
    Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pharmacy intervention on aminoglycoside costs.
    Tsuyuki RT; Nakagawa RS
    Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist interventions to improve prescribing of vancomycin and tobramycin.
    Fletcher CV; Giese RM; Rodman JH
    Am J Hosp Pharm; 1986 Sep; 43(9):2198-201. PubMed ID: 3766572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost savings associated with use of gentamicin versus tobramycin.
    Schwinghammer TL; Romano MJ; Wing EJ
    Am J Hosp Pharm; 1985 Aug; 42(8):1745-9. PubMed ID: 4036972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacist impact on parenteral cephalosporin prescribing.
    Lawlor MC; Lucarotti RL
    Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate but not cost effective ceftazidime use in a university hospital.
    Colburn PA; Carver PA; Montgomery PA; Alaniz C; Chaffee BW; Amesbury BK
    Hosp Pharm; 1989 Nov; 24(11):911-6, 928. PubMed ID: 10313376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic.
    Jones RA; Lopez LM; Beall DG
    Hosp Pharm; 1991 Sep; 26(9):778-82. PubMed ID: 10114011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial impact of an aminoglycoside substitution program.
    Andrews JD; Stad K
    Can J Hosp Pharm; 1987 Feb; 40(1):23-6. PubMed ID: 10281256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aminoglycoside-use restrictions on drug cost.
    DeTorres OH; White RE
    Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical considerations and costs associated with formulary conversion from tobramycin to gentamicin.
    Green ER; Chrymko MM; Rozek SL; Kitrenos JG
    Am J Hosp Pharm; 1989 Apr; 46(4):714-9. PubMed ID: 2719049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing the clinical pharmacist to modify tobramycin dosage regimens: accuracy of prediction and potential cost effectiveness.
    Sesin GP; Baptista RJ
    Hosp Pharm; 1984 Dec; 19(12):806-7, 810. PubMed ID: 10310905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective audit of an aminoglycoside consultative service in a general hospital.
    Li SC; Ioannides-Demos LL; Spicer WJ; Spelman DW; Tong N; McLean AJ
    Med J Aust; 1992 Sep; 157(5):308-11. PubMed ID: 1435470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycoside use monitored by clinical pharmaceutical services.
    Barriere SL; Conte JE
    Am J Hosp Pharm; 1979 Sep; 36(9):1209-11. PubMed ID: 495621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist-physician cooperation in the use of high-cost drugs.
    Oddis JA
    Resid Staff Physician; 1988 May; 34(6):13, 16. PubMed ID: 10287353
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.